MaaT Pharma is focused on developing microbiome ecosystem therapies to improve patient health, with a pipeline that includes innovative products like Xervyteg® and MaaT033
MaaT Pharma is focused on developing microbiome ecosystem therapies to improve patient health, with a pipeline that includes innovative products like Xervyteg® and MaaT033.